Evidence map›Paper›PMID 26080397›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.

Kiran Kumar Nakka, Nidhi Chaudhary, Shruti Joshi, Jyotsna Bhat, Kulwant Singh, Subhrangsu Chatterjee, Renu Malhotra, Abhijit De, Manas Kumar Santra, F Jeffrey Dilworth and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Role of Sam68 in different types of cancer (Review).International journal of molecular medicine · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. RNA-binding proteins in tumor progression.Journal of hematology & oncology · 2020
    Review
  15. Roles of Splicing Factors in Hormone-Related Cancer Progression.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Kiran Kumar NakkaChromatin and Disease Biology Laboratory, National Centre for Cell Science, Pune 411007, India; Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada;
Nidhi ChaudharyChromatin and Disease Biology Laboratory, National Centre for Cell Science, Pune 411007, India;
Shruti JoshiChromatin and Disease Biology Laboratory, National Centre for Cell Science, Pune 411007, India;
Jyotsna BhatDepartment of Biophysics, Bose Institute, Kolkata 700054, India;
Kulwant SinghSprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada;
Subhrangsu ChatterjeeDepartment of Biophysics, Bose Institute, Kolkata 700054, India;
Renu MalhotraAdvanced Center for Treatment, Education and Research, Tata Memorial Centre, Navi Mumbai 410210, India;
Abhijit DeAdvanced Center for Treatment, Education and Research, Tata Memorial Centre, Navi Mumbai 410210, India;
Manas Kumar SantraCancer and Epigenetics Lab, National Centre for Cell Science, Pune 411007, India;
F Jeffrey DilworthSprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, K1H 8L6, Canada.
Samit ChattopadhyayChromatin and Disease Biology Laboratory, National Centre for Cell Science, Pune 411007, India; samit@nccs.res.in.
National Centre for Cell Science · INBose Institute · INTata Memorial Hospital · INOttawa Hospital · CAOttawa Hospital Research Institute

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Pre-mRNA splicing is a complex regulatory nexus modulated by various trans-factors and their posttranslational modifications to create a dynamic transcriptome through alternative splicing. Signal-induced phosphorylation and dephosphorylation of trans-factors are known to regulate alternative splicing. However, the role of other posttranslational modifications, such as deacetylation/acetylation, methylation, and ubiquitination, that could modulate alternative splicing in either a signal-dependent or -independent manner remain enigmatic. Here, we demonstrate that Scaffold/matrix-associated region-binding protein 1 (SMAR1) negatively regulates alternative splicing through histone deacetylase 6 (HDAC6)-mediated deacetylation of RNA-binding protein Sam68 (Src-associated substrate during mitosis of 68 kDa). SMAR1 is enriched in nuclear splicing speckles and associates with the snRNAs that are involved in splice site recognition. ERK-MAPK pathway that regulates alternative splicing facilitates ERK-1/2-mediated phosphorylation of SMAR1 at threonines 345 and 360 and localizes SMAR1 to the cytoplasm, preventing its interaction with Sam68. We showed that endogenously, SMAR1 through HDAC6 maintains Sam68 in a deacetylated state. However, knockdown or ERK-mediated phosphorylation of SMAR1 releases the inhibitory SMAR1-HDAC6-Sam68 complex, facilitating Sam68 acetylation and alternative splicing. Furthermore, loss of heterozygosity at the Chr.16q24.3 locus in breast cancer cells, wherein the human homolog of SMAR1 (BANP) has been mapped, enhances Sam68 acetylation and CD44 variant exon inclusion. In addition, tail-vein injections in mice with human breast cancer MCF-7 cells depleted for SMAR1 showed increased CD44 variant exon inclusion and concomitant metastatic propensity, confirming the functional role of SMAR1 in regulation of alternative splicing. Thus, our results reveal the complex molecular mechanism underlying SMAR1-mediated signal-dependent and -independent regulation of alternative splicing via Sam68 deacetylation.

Indexed as

AcetylationAdaptor Proteins, Signal TransducingAlternative SplicingCell Cycle ProteinsCytoplasmDNA-Binding ProteinsGene Knockdown TechniquesHistone Deacetylase 6Histone DeacetylasesHumansHyaluronan ReceptorsMAP Kinase Signaling SystemNuclear MatrixNuclear ProteinsProtein TransportRNA-Binding ProteinsAdaptor Proteins, Signal TransducingBANP protein, humanCD44 protein, humanCell Cycle ProteinsDNA-Binding ProteinsHDAC6 protein, humanHistone Deacetylase 6Histone DeacetylasesHyaluronan ReceptorsKHDRBS1 protein, humanNuclear ProteinsRNA-Binding Proteinsalternative splicingdeacetylationHDAC6Sam68SMAR1

Identifiers

PMID26080397
PMCPMC4491761
OpenAlexW1563678203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.